Home
Search:
1146 feeds
357 categories
3665 articles (<24 hours)
16 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

Science


Valid HTML 4.01 Transitional

RSS FeedsInitiator Pharma A/S secures bridge financing in preparation of a clinical phase 2a trial for the candidate drug IP2018
(World News Science)

 
 

13 august 2019 15:40:21

 
Initiator Pharma A/S secures bridge financing in preparation of a clinical phase 2a trial for the candidate drug IP2018
(World News Science)
 




Initiator Pharma A/S (`Initiator Pharma`) is currently conducting a clinical phase 2a trial for the company`s main candidate IPED2015, which is intended to be completed later in the summer. Initiator Pharma is now able to announce that the company has secured bridge financing of SEK 5 million with the aim pf preparing the company`s other candidate drug IP2018 for the start of a clinical phase 2a trial. With this bridge financing, the company is able to conduct activities for added value before seeking more long-term funding. The clinical phase 2a trial regarding IP2018 is expected to begin in early 2020. IP2018 - positioning in the market for depression and erectile dysfunction Initiator...
 
56 viewsCategory: Science
 
The journey to interoperability: A healthcare industry-wide transformation
(World News Science)
ETTEPLAN Q2 2019 published: Growth continued and profitability exceeded the target level
(World News Science)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2019 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Travel Photos Nachrichten Indigonet Finances Leer Mandarijn